Delivery Order SPE2DB20D1004-SPE2DB25F1694
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,222.50 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules in quantities of 10 units. The contract, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, utilizes firm fixed price terms and carries no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a $1,567.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by June 2, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30, with a ceiling value of $2,347.10. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,763.80 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical distributor specializing in medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.28 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract valued at $4,335.66. The order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a small-value pharmaceutical procurement without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office...
- The Defense Logistics Agency awarded a $1,226.11 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count packaging). This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 2, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,034.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (10-count units) on April 22, 2025, with an ultimate completion date of April 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25F1694Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $4,107.42. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems and holds a comprehensive IDC valued at $999.999 billion through December 2026, designated SPE2DX, which enables the company to supply a broad range of pharmaceutical products and medical commodities globally. This delivery order supports the Defense Logistics Agency's medical supply chain operations and represents a continuation of AmerisourceBergen's established role as a prime vendor for federal pharmaceutical procurement. The contract reflects the competitive, open-award practices that characterize the company's federal business, with pricing structured as a firm fixed-price delivery order. Isotretinoin is a prescription medication commonly used in military and federal healthcare settings, and this order fulfills specific medical supply requirements within the broader DLA Troop Support Medical program that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/3/25 |